253 related articles for article (PubMed ID: 22496875)
1. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.
Turunen SP; Kummu O; Harila K; Veneskoski M; Soliymani R; Baumann M; Pussinen PJ; Hörkkö S
PLoS One; 2012; 7(4):e34910. PubMed ID: 22496875
[TBL] [Abstract][Full Text] [Related]
2. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
3. Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein.
Kyrklund M; Kummu O; Kankaanpää J; Akhi R; Nissinen A; Turunen SP; Pussinen P; Wang C; Hörkkö S
PLoS One; 2018; 13(1):e0191216. PubMed ID: 29329335
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein modifications by gingipains of Porphyromonas gingivalis.
Lönn J; Ljunggren S; Klarström-Engström K; Demirel I; Bengtsson T; Karlsson H
J Periodontal Res; 2018 Jun; 53(3):403-413. PubMed ID: 29341140
[TBL] [Abstract][Full Text] [Related]
5. Functional characteristics of antibodies induced by Arg-gingipain (HRgpA) and Lys-gingipain (Kgp) from Porphyromonas gingivalis.
Nakagawa T; Sims T; Fan Q; Potempa J; Travis J; Houston L; Page RC
Oral Microbiol Immunol; 2001 Aug; 16(4):202-11. PubMed ID: 11442844
[TBL] [Abstract][Full Text] [Related]
6. Existence of natural mouse IgG mAbs recognising epitopes shared by malondialdehyde acetaldehyde adducts and
Kyrklund M; Kaski H; Akhi R; Nissinen AE; Kummu O; Bergmann U; Pussinen P; Hörkkö S; Wang C
Innate Immun; 2021 Feb; 27(2):158-169. PubMed ID: 33445998
[TBL] [Abstract][Full Text] [Related]
7. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
[TBL] [Abstract][Full Text] [Related]
8. Specific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.
Kuboniwa M; Amano A; Shizukuishi S; Nakagawa I; Hamada S
Infect Immun; 2001 May; 69(5):2972-9. PubMed ID: 11292714
[TBL] [Abstract][Full Text] [Related]
9. Identification of gingipain-specific I-A(b) -restricted CD4+ T cells following mucosal colonization with Porphyromonas gingivalis in C57BL/6 mice.
Bittner-Eddy PD; Fischer LA; Costalonga M
Mol Oral Microbiol; 2013 Dec; 28(6):452-66. PubMed ID: 23945018
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis.
O'Brien-Simpson NM; Black CL; Bhogal PS; Cleal SM; Slakeski N; Higgins TJ; Reynolds EC
Infect Immun; 2000 May; 68(5):2704-12. PubMed ID: 10768963
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses of periodontitis patients to gingipains of Porphyromonas gingivalis.
Inagaki S; Ishihara K; Yasaki Y; Yamada S; Okuda K
J Periodontol; 2003 Oct; 74(10):1432-9. PubMed ID: 14653388
[TBL] [Abstract][Full Text] [Related]
12. Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
Gibson FC; Savelli J; Van Dyke TE; Genco CA
J Periodontol; 2005 Oct; 76(10):1629-36. PubMed ID: 16253083
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.
Akhi R; Wang C; Kyrklund M; Kummu O; Turunen SP; Hyvärinen K; Kullaa A; Salo T; Pussinen PJ; Hörkkö S
J Clin Periodontol; 2017 Jul; 44(7):682-691. PubMed ID: 28548243
[TBL] [Abstract][Full Text] [Related]
14. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model.
O'Brien-Simpson NM; Paolini RA; Reynolds EC
Infect Immun; 2000 Jul; 68(7):4055-63. PubMed ID: 10858222
[TBL] [Abstract][Full Text] [Related]
15. Production of protective antibodies against Porphyromonas gingivalis strains by immunization with recombinant gingipain domains.
Yasaki-Inagaki Y; Inagaki S; Yamada S; Okuda K; Ishihara K
FEMS Immunol Med Microbiol; 2006 Jul; 47(2):287-95. PubMed ID: 16831217
[TBL] [Abstract][Full Text] [Related]
16. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
17. Pep19 drives epitope spreading in periodontitis and periodontitis-associated autoimmune diseases.
Kwon EY; Cha GS; Jeong E; Lee JY; Kim SJ; Surh CD; Choi J
J Periodontal Res; 2016 Jun; 51(3):381-94. PubMed ID: 26362417
[TBL] [Abstract][Full Text] [Related]
18. Identification and Modification of
Hirai K; Yamaguchi-Tomikawa T; Eguchi T; Maeda H; Takashiba S
Front Immunol; 2020; 11():1017. PubMed ID: 32582160
[TBL] [Abstract][Full Text] [Related]
19. Selective proteolysis of apolipoprotein B-100 by Arg-gingipain mediates atherosclerosis progression accelerated by bacterial exposure.
Hashimoto M; Kadowaki T; Tsukuba T; Yamamoto K
J Biochem; 2006 Nov; 140(5):713-23. PubMed ID: 17030507
[TBL] [Abstract][Full Text] [Related]
20. Serum antibodies against the hemoglobin-binding domain (HA2) of Porphyromonas gingivalis.
DeCarlo AA; Nadkarni M; Paramaesvaran M; Yun PW; Collyer CA; Hunter N
J Periodontal Res; 2004 Aug; 39(4):228-35. PubMed ID: 15206915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
